Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGFBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDV3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC11A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SECISBP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD18A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GFPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC11C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC61B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIS3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on